bioRxiv · 10.1101/2024.10.09.617482
MANGIFERIN AS A POTENTIAL INHIBITOR OF TRANSTHYRETIN FIBRILOGENESIS
Abstract
By using in silico molecular docking, we predicted a high potential of mangiferin to inhibit transthyretin amyloidogenesis. Subsequently, we tested this prediction in an in vitro system. The study involved testing effect of mangiferrin in a system that included isolated and purified recombinant transthyretin under fibrillogenesis conditions and a detection assay based on the fluorescent dye thioflavin T, characteristic of amyloid fibrils. The conditions for fibrillogenesis of this protein at neutral pH values were established. Using the developed test system, it was shown that mangiferin is able to inhibit abnormal transthyretin fibrillogenesis.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Grudinina, N., Petukhov, M. G., Shaldzhyan, A. A., Zabrodskaya, Y. A., Gavrilova, N. V., Morozkina, S. N., Egorov, V. V.. 2024-10-10. MANGIFERIN AS A POTENTIAL INHIBITOR OF TRANSTHYRETIN FIBRILOGENESIS. https://doi.org/10.1101/2024.10.09.617482
Cite the original work for its findings. Save a collection to share your selection of sources.